|
Quotes & Info
|
| ORCL > SEC Filings for ORCL > Form 8-K on 8-Jul-2009 | All Recent SEC Filings |
8-Jul-2009
Other Events, Financial Statements and Exhibits
Issuance of $4.50 Billion of Notes
On July 8, 2009, Oracle Corporation ("Oracle") consummated the issuance and sale of $1,500,000,000 principal amount of its 3.750% Notes due 2014, $1,750,000,000 principal amount of its 5.000% Notes due 2019 and $1,250,000,000 principal amount of its 6.125% Notes due 2039 (collectively, the "Notes"), pursuant to an underwriting agreement dated June 30, 2009 among Oracle and Banc of America Securities LLC, Morgan Stanley & Co. Incorporated and Wachovia Capital Markets, LLC, as representatives of the several underwriters named therein. The Notes will be issued pursuant to an Indenture dated as of January 13, 2006 (the "Indenture") among Oracle (formerly known as Ozark Holding Inc.), Oracle Systems Corporation (formerly known as Oracle Corporation) and Citibank, N.A., as amended by the First Supplemental Indenture dated as of May 9, 2007 (the "First Supplemental Indenture") among Oracle, Citibank, N.A. and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee, and an officers' certificate issued pursuant thereto.
The Notes were offered pursuant to Oracle's Registration Statement on Form S-3 filed on May 10, 2007 (Reg. No. 333-142796), including the prospectus contained therein (the "Registration Statement"), and a related preliminary prospectus supplement dated June 30, 2009 and a prospectus supplement dated June 30, 2009.
The material terms and conditions of the Notes are set forth in the Form of Officers' Certificate filed herewith as Exhibit 4.08 and incorporated by reference herein and in the Indenture filed as Exhibit 10.34 to the Current Report on Form 8-K filed by Oracle Systems Corporation on January 20, 2006, and the First Supplemental Indenture filed as Exhibit 4.3 to the Registration Statement.
(d) Exhibits
Exhibit No. Description 4.08 Form of Officers' Certificate setting forth the terms of the Notes 5.01 Opinion of Davis Polk & Wardwell LLP 23.02 Consent of Davis Polk & Wardwell LLP (contained in Exhibit 5.01) |
|
|